IPO registrations (S-1, F-1) · Registrants
RIGEL PHARMACEUTICALS INC
- SEC CIK
- 1034842 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2000-02-04, last 2000-11-22; 2 initial registrations, 9 amendments
- Outcome
- Final prospectus filed 2000-11-29; withdrawal requested 2000-04-13
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, South San Francisco, CA 94080
- EIN
- 94-3248524
- Ticker
- RIGL (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- RIGEL PHARMACEUTICALS INC on the corporate pages
Offering terms
- Proposed price range
- $7.00–$8.00 per share (S-1/A filed 2000-11-22)
- Final price
- $7.00 per share, within the range (424B4 filed 2000-11-29, an initial public offering)
- Shares sold
- 5,000,000
- Gross proceeds
- $35,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol RIGL
- Lead underwriters
- Morgan Stanley; Lehman Brothers (1,083,400 shares); Robertson Stephens (1,083,400 shares)
- Syndicate
- William Blair (83,300); RBC Capital Markets (83,300); Wachovia (83,300); Janney Montgomery Scott (83,300); Edward D. Jones & Co., L.P (83,300); Needham & Company (83,300); UBS (83,300)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: RIGEL PHARMACEUTICALS INC EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Rigel Pharmaceuticals, Inc. Fuzzy (name and state)
- Business registration: Rigel Pharmaceuticals, Inc. Fuzzy (name and state)
- Business registration: Rigel Pharmaceuticals, Inc. Fuzzy (name and state)
- Business registration: Rigel Pharmaceuticals, Inc. Fuzzy (name and state)
- Business registration: RIGEL PHARMACEUTICALS, Inc. Fuzzy (name and state)
- Business registration: RIGEL PHARMACEUTICALS INC Fuzzy (name and state)
- Business registration: RIGEL PHARMACEUTICALS, INC. Fuzzy (name and state)
- Business registration: RIGEL PHARMACEUTICALS, INC. Fuzzy (name and state)
- Business registration: RIGEL PHARMACEUTICALS, INC. Fuzzy (name and state)
- Business registration: RIGEL PHARMACEUTICALS, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: RIGEL PHARMACEUTICALS INC. EXACT (EIN (EXACT))
- Federal award recipient: RIGEL PHARMACEUTICALS INC Fuzzy (name and state)
- Lobbying client: RIGEL PHARMACEUTICALS INC. Fuzzy (name and state)
- SEC filer: RIGEL PHARMACEUTICALS INC EXACT (CIK (EXACT))
- Person page: James E Flynn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther))
Filings 13
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-02-04 | S-1 | S-1 (registration) | RIGEL PHARMACEUTICALS INC | 0000912057-00-003828 ↗ |
| 2000-03-08 | S-1/A | S-1/A (amendment) | RIGEL PHARMACEUTICALS INC | 0000912057-00-010469 ↗ |
| 2000-03-24 | S-1/A | S-1/A (amendment) | RIGEL PHARMACEUTICALS INC | 0000912057-00-013274 ↗ |
| 2000-03-24 | S-1/A | S-1/A (amendment) | RIGEL PHARMACEUTICALS INC | 0000912057-00-013488 ↗ |
| 2000-03-28 | S-1/A | S-1/A (amendment) | RIGEL PHARMACEUTICALS INC | 0000912057-00-013988 ↗ |
| 2000-04-11 | S-1/A | S-1/A (amendment) | RIGEL PHARMACEUTICALS INC | 0000912057-00-017467 ↗ |
| 2000-04-13 | RW | RW (withdrawal request) | RIGEL PHARMACEUTICALS INC | 0000912057-00-017932 ↗ |
| 2000-09-15 | S-1 | S-1 (registration) | RIGEL PHARMACEUTICALS INC | 0000912057-00-041537 ↗ |
| 2000-10-02 | S-1/A | S-1/A (amendment) | RIGEL PHARMACEUTICALS INC | 0000912057-00-043386 ↗ |
| 2000-10-16 | S-1/A | S-1/A (amendment) | RIGEL PHARMACEUTICALS INC | 0000912057-00-044783 ↗ |
| 2000-11-17 | S-1/A | S-1/A (amendment) | RIGEL PHARMACEUTICALS INC | 0000912057-00-050782 ↗ |
| 2000-11-22 | S-1/A | S-1/A (amendment) | RIGEL PHARMACEUTICALS INC | 0000912057-00-051139 ↗ |
| 2000-11-29 | 424B4 | 424B4 (final prospectus) | RIGEL PHARMACEUTICALS INC | 0000912057-00-051611 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-11-22 | S-1/A | registration statement | $7.00–$8.00 | 5,000,000 | - | Nasdaq RIGL | 3 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 3 | document ↗ | |
| 2000-11-29 | 424B4 | final prospectus | $7.00 | 5,000,000 | $35,000,000 | Nasdaq RIGL | 10 | primary document; price sentence, shares headline, proceeds computed, underwriting table 9, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| COOPER ROBIN D G | Officer | Sr. V.P. Pharmaceutical Scs. | 4 | 2006–2008 | |
| GOWER JAMES M | Director,Officer | CEO & Board Chairman | 10 | 2006–2014 | |
| GROSSBARD ELLIOT B | Officer | EVP, CMO; Sr. VP Medical Development | 13 | 2006–2016 | |
| PAYAN DONALD G | Director,Officer | EVP, Pres. Discovery&Research; Ex. VP Chief Sci. Officer | 19 | 2006–2016 | |
| RODRIGUEZ RAUL R | Director,Officer; Officer | CEO, President; EVP, COO; President & COO | 48 | 2006–2026 | |
| VANCE DOLLY | Officer | EVP Corp. Affairs, G.C., Sect.; SVP, Gen. Counsel, Corp. Sec.; VP Intel. Prop.& Gen.Counsel | 30 | 2006–2022 | |
| WELCH JAMES H | Officer | CFO, VP & Secretary | 1 | 2006 | |
| FRAZIER ALAN D | Director | 3 | 2006 | ||
| LYONS GARY A | Director | 18 | 2006–2023 | ||
| MOOS WALTER H | Director | 24 | 2006–2026 | ||
| RENTON HOLLINGS | Director | 8 | 2006–2013 | ||
| RINGROSE PETER S | Director | 13 | 2006–2018 | ||
| DELEAGE JEAN | Director | 6 | 2006–2010 | ||
| SHERWIN STEPHEN A | Director | 12 | 2006–2016 | ||
| Maynard Ryan D | Officer | EVP & CFO; VP, CFO; VP Finance, Acting CFO | 21 | 2006–2017 | |
| Goodwin Bradford S | Director | 18 | 2007–2021 | ||
| DEERFIELD CAPITAL LP | TenPercentOwnerOther | 3 | 2010–2011 | ||
| DEERFIELD INTERNATIONAL LTD | TenPercentOwnerOther | 3 | 2010–2011 | ||
| DEERFIELD MANAGEMENT CO /NY | TenPercentOwnerOther | 3 | 2010–2011 | ||
| DEERFIELD PARTNERS, LP | TenPercentOwnerOther | 3 | 2010–2011 | ||
| Deerfield Special Situations Fund International LTD | TenPercentOwnerOther | 3 | 2010–2011 | ||
| Deerfield Special Situations Fund, L.P. | TenPercentOwnerOther | 3 | 2010–2011 | ||
| Flynn James E | TenPercentOwnerOther | 3 | 2010–2011 | person page Fuzzy | |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 3 | 2013 | ||
| BIOTECHNOLOGY VALUE FUND L P | Other | 3 | 2013 | ||
| BVF INC/IL | TenPercentOwner | 3 | 2013 | ||
| BVF INVESTMENTS LLC | Other | 3 | 2013 | ||
| BVF PARTNERS L P/IL | TenPercentOwner | 3 | 2013 | ||
| INVESTMENT 10 LLC | Other | 1 | 2013 | ||
| LAMPERT MARK N | TenPercentOwner | 3 | 2013 | ||
| Katkin Keith | Director | 8 | 2015–2021 | ||
| Duliege Anne-Marie | Officer | Chief Medical Officer; EVP & Chief Medical Officer | 13 | 2016–2019 | |
| Lasaga Joseph | Officer | Sr.VP Bus.Dev.Alliance Mgmt.; VP Bus. Dev.& Alliance Mgmt. | 8 | 2016–2019 | |
| Masuda Esteban | Officer | Sr. VP Research | 7 | 2016–2019 | |
| Mayer Eldon C. III | Officer | EVP & Chief Commercial Officer; EVP &Chief Commercial Officer | 10 | 2016–2019 | |
| Kotzin Brian L. | Director | 9 | 2017–2024 | ||
| LAPOINTE ANTHONY GREGG | Director | 11 | 2017–2026 | ||
| Cabatuan Nelson | Officer | Principal Accounting Officer; VP,Finance & Princ.Acctg. Off. | 7 | 2017–2020 | |
| Markel Stacy | Officer | EVP Human Resources | 4 | 2018–2019 | |
| Schorno Dean L | Officer | EVP & Chief Financial Officer; EVP &Chief Financial Officer | 31 | 2018–2026 | |
| Wasman Jane | Director | 10 | 2019–2026 | ||
| Dummer Wolfgang | Officer | Chief Medical Officer; EVP & CMO | 8 | 2019–2023 | |
| Santos David A | Officer | EVP, Chief Commercial Officer | 21 | 2020–2026 | |
| HANNAH ALISON L. | Director; Officer | EVP, Chief Medical Officer | 9 | 2021–2026 | |
| Ali-Jackson Kamil | Director | 9 | 2021–2026 | ||
| Furey Raymond J. | Officer | EVP, GC, CCO & Corp Sec; EVP, GC & Corp Sec | 13 | 2022–2026 | |
| Rojkjaer Lisa | Officer | EVP, Chief Medical Officer | 9 | 2024–2026 | |
| Frohlich Mark W | Director | 4 | 2025–2026 | ||
| MILLER MICHAEL PATRICK | Director | 3 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Rigel Pharmaceuticals, Inc. | CA | State business registries | name and state |
| Business registration | Rigel Pharmaceuticals, Inc. | CA | State business registries | name and state |
| Business registration | Rigel Pharmaceuticals, Inc. | CA | State business registries | name and state |
| Business registration | Rigel Pharmaceuticals, Inc. | CA | State business registries | name and state |
| Business registration | RIGEL PHARMACEUTICALS, Inc. | CA | State business registries | name and state |
| Business registration | RIGEL PHARMACEUTICALS INC | CA | State business registries | name and state |
| Business registration | RIGEL PHARMACEUTICALS INC | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | RIGEL PHARMACEUTICALS, INC. | CA | State business registries | name and state |
| Business registration | RIGEL PHARMACEUTICALS, INC. | CA | State business registries | name and state |
| Business registration | RIGEL PHARMACEUTICALS, INC. | CA | State business registries | name and state |
| Business registration | RIGEL PHARMACEUTICALS, INC. | CA | State business registries | name and state |
| Federal award recipient | RIGEL PHARMACEUTICALS INC | CA | Federal spending (USAspending) | name and state |
| Lobbying client | RIGEL PHARMACEUTICALS INC. | CA | Federal lobbying (LDA) | name and state |
| Paying company | Rigel Pharmaceuticals, Inc. | CA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Rigel Pharmaceuticals, Inc. | CA | Patents (USPTO) | name and state |
| SEC filer | RIGEL PHARMACEUTICALS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Rigel Pharmaceuticals, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | RIGEL PHARMACEUTICALS INC. | EIN (EXACT) | ||
| Person page | James E Flynn | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CA first:
- CONNETICS CORP CA
- SIBIA NEUROSCIENCES INC CA
- MEDIVATION, INC. CA
- IMMUSOL INC CA
- DYNAVAX TECHNOLOGIES CORP CA
- Diadexus, Inc. CA
- CymaBay Therapeutics, Inc. CA
- CRESCENDO PHARMACEUTICALS CORP CA
- SPIROS DEVELOPMENT CORP II INC CA
- BIOMARIN PHARMACEUTICAL INC CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health